Cholestech - Crunchbase Company Profile & Funding

Q: When was the last funding round for Cholestech?

Cholestech closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Cholestech raised to date?

Cholestech has raised obfuscated.

Overview

Cholestech

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Cholestech

CB Rank

570969

Cholestech develops point-of-care diagnostics solutions for chronic diseases.

Acquired by

Inverness Medical

Founded

obfuscation

Private

Series B

San Diego, California, United States

251-500

www.globalpointofcare.abbott/en/product-details...

Health Care

Health Diagnostics

Medical

Funding Rounds

Series B

OBF

obfuscation

Details

Legal Name

Cholestech Corporation

Operating Status

Closed

Company Type

For Profit

About the Company

Cholestech develops point-of-care diagnostics solutions for chronic diseases. Cholestech is famous for its flagship product Cholestech LDX (R) measures cholesterol, glucose, liver enzymes, and C-reactive Protein to identify high-risk heart disease patients. It was founded in 1988 and is based in San Diego, California.

In June 2007, Alere (then

known as Inverness Medical) acquired the company for $326.3M.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cholestech LDX™ Analyzer

A point-of-care diagnostic device that provides lipid and glucose test results within five minutes to aid in cardiovascular and diabetes patient management.

Bioline™ HIV/Syphilis Duo

A rapid lateral flow test that simultaneously detects HIV and syphilis infections to support same-day diagnosis and treatment.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cholestech	—	obfuscated obfuscation	—	Series B